Formulation & Evaluation of Dexamethasone Matrix: Tablets for Poly Cystic Ovarian Syndrome (For the treatment of Polysyst) - Couverture souple

Kaurav, Rampal Singh; Gupta, Ravikant

 
9786204983424: Formulation & Evaluation of Dexamethasone Matrix: Tablets for Poly Cystic Ovarian Syndrome (For the treatment of Polysyst)
Couverture souple
ISBN 10 : 6204983423 ISBN 13 : 9786204983424
Editeur : LAP LAMBERT Academic Publishing, 2022

Synopsis

The aim of this study is to prepare matrix tablets of dexamethasone, that can manage the various factors-Patient compliances and conveniences, Manage time for administrating the drug, Reduce multiple doses ofdexamethasone, Desired therapeutic effect.The basic approach in development of matrix tablets is the use of co-processed diluents like micro crystalline cellulose (MCC), magnesium stearate, lactose etc and natural polymer like traganth gum provide slow disintegration of tablets after putting in oral cavity, thereby release the drug in stomach. The bioavailability of some drugs may be decreased due to absorption of drugs in saliva and also due to pregastric absorption of saliva containing dispersed drugs that pass down into the stomach.In this study I have chosen dexamethasone drug because it having half life of 4-6 hours and can be formulated as sustain type drug.Tablet formulation on the basis of optimized batch had 1.6% of dexamethasone with 98.4% excipients. In conclusion, it can be said that the studies were helpful in evolving sustain release or matrix tablets of dexamethasone.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Éditeur
LAP LAMBERT Academic Publishing
Date d'édition
2022
Langue
anglais
ISBN 10 
6204983423
ISBN 13 
9786204983424
Reliure
Broché
Nombre de pages
92
Coordonnées du fabricant
non disponible
Personne responsable
KreGa Onlinehandel GmbH
4950000000000
info@krega-onlinehandel.de

Birkenweg 31
Brakel
33034
Allemagne